FOLH1 and prostate carcinoma: These results are concordant with the findings previously demonstrated using 68Ga-PSMA PET/CT [19, 21, 22], and whilst expected, these findings are an important step to validate the role of [18F]PSMA-1007 PET/CT in primary prostate cancer staging.